Boping Zhou

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 6

Top Topics

Reactive Oxygen Species

Signaling Pathway

Top Venues

Oxidative medicine and cellular longevity

Journal of clinical and translational hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Liming Zhou, Xiaobin Zeng, Xiaofang Wei, Wanying Shen, Jie Yao, Weigang Wu, Lanlan Ge, Boping Zhou
Bao-Gan-Xiao-Zhi-Wan Treatment Attenuates Methionine-choline-deficient Diet-induced Metabolic Dysfunction-associated Steatohepatitis in Rats by Modulating the NF-κB Signal Pathway and Autophagy. Journal of clinical and translational hepatology 12 (6) (2024)
Liming Zhou, Xiaobin Zeng, Xiaofang Wei, Wanying Shen, Jie Yao, Weigang Wu, Lanlan Ge, Boping Zhou
Bao-Gan-Xiao-Zhi-Wan Treatment Attenuates Methionine-choline-deficient Diet-induced Metabolic Dysfunction-associated Steatohepatitis in Rats by Modulating the NF-κB Signal Pathway and Autophagy. Journal of clinical and translational hepatology 12 (6) (2024)
Haoqiang Wan, Yi Cai, Lingyun Xiao, Yunzhi Ling, Lanlan Ge, Siwei Mo, Qiujie Xie, Shusong Peng, Boping Zhou, Xiaobin Zeng, Xinchun Chen
JFD, a Novel Natural Inhibitor of Keap1 Alkylation, Suppresses Intracellular Mycobacterium Tuberculosis Growth through Keap1/Nrf2/SOD2-Mediated ROS Accumulation. Oxidative medicine and cellular longevity 2023 (2023)
Haoqiang Wan, Yi Cai, Lingyun Xiao, Yunzhi Ling, Lanlan Ge, Siwei Mo, Qiujie Xie, Shusong Peng, Boping Zhou, Xiaobin Zeng, Xinchun Chen
JFD, a Novel Natural Inhibitor of Keap1 Alkylation, Suppresses Intracellular Mycobacterium Tuberculosis Growth through Keap1/Nrf2/SOD2-Mediated ROS Accumulation. Oxidative medicine and cellular longevity 2023 (2023)
Haoqiang Wan, Yi Cai, Lingyun Xiao, Yunzhi Ling, Lanlan Ge, Siwei Mo, Qiujie Xie, Shusong Peng, Boping Zhou, Xiaobin Zeng, Xinchun Chen
JFD, a Novel Natural Inhibitor of Keap1 Alkylation, Suppresses Intracellular Mycobacterium Tuberculosis Growth through Keap1/Nrf2/SOD2-Mediated ROS Accumulation. Oxidative medicine and cellular longevity 2023 (2023)
Haoqiang Wan, Yi Cai, Lingyun Xiao, Yunzhi Ling, Lanlan Ge, Siwei Mo, Qiujie Xie, Shusong Peng, Boping Zhou, Xiaobin Zeng, Xinchun Chen
JFD, a Novel Natural Inhibitor of Keap1 Alkylation, Suppresses Intracellular Mycobacterium Tuberculosis Growth through Keap1/Nrf2/SOD2-Mediated ROS Accumulation. Oxidative medicine and cellular longevity 2023 (2023)